About
Dana McAfee Hammill is president and owner of RnR Biomedical Solutions, a limited liability company that provides advisory, strategy, and management services to life science companies and academics, specifically in the field of cell and gene therapies.
Ms. Hammill earned a Masters in Business Administration with a concentration in Leadership from Saint Joseph's University, and a Masters of Molecular Biotechnology from University of Pennsylvania School of Engineering and Applied Science with a concentration in gene therapy and genetic engineering. She attended Cook College at Rutgers University and earned a Bachelor of Science in Biotechnology. She also attended The Wharton School, completing the 2-year Wharton Management Program with honors.
- Expertise in cell and gene therapies
- Knowledge of FDA regulations for operation and compliance of GLP, GMP, GCP, and Good Clinical Laboratory Practices
- Development of GxP programs
- Biomedical entrepreneurship and business development
- Technology discovery and proof of concept through product development, funding, clinical trials, and technology transfer
- IND and clinical trial development
- Strategic planning and execution
- Alliance management
- Negotiation and mediation
- Operational and financial management
- Career development
- Mentorship
- Driving Strategic Innovation at The Wharton School (online)
- Program on Negotiation at Harvard Law School – Advanced Negotiation: Making Difficult Conversations Productive
- Program on Negotiation at Harvard Law School – Negotiation Master ClassGood Laboratory Practices, Beyond Basics
- Collaborative Institutional Training Initiative (CITI), HIPPA
- Clinical research associate
- LeadingSuccess™
- Overview of FDA and ICH Good Clinical Practices – Regulations and Guidance for the Conduct of Clinical Trials
- GLP Vendor Audits
- Practical Approaches for Validating Computer Systems in the FDA-Regulated Environment